Across TCGA pan-cancer cohorts, LINC01602 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC01602 data layer.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC01602 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01602 expression acts as an unfavorable survival marker, although some lineages such as LGG and READ show a favorable association.
COAD, KIRP, and KICH are the cancer types where LINC01602 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.